Decreased stability of transforming growth factor beta type II receptor mRNA in RER+ human colon carcinoma cells

W Jiang1, M P Tillekeratne, M G Brattain

  • 1Department of Biochemistry and Molecular Biology, Medical College of Ohio, Toledo 43699, USA.

Biochemistry
|December 24, 1997
PubMed

Insights

Loss of functional transforming growth factor beta type II receptor (RII) in colon cancer cells is due to decreased mRNA stability, not reduced transcription. A frameshift mutation causes premature stop codons, leading to reduced RII mRNA levels.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Transforming growth factor beta (TGF-beta) inhibits cell growth and tumor progression.
  • Loss of functional TGF-beta type II receptor (RII) confers TGF-beta resistance.
  • A frameshift mutation in the RII gene is linked to TGF-beta resistance in HCT116 colon cancer cells.

Purpose of the Study:

  • To investigate the mechanism underlying the reduced expression of the mutated TGF-beta type II receptor (RII) in RER+ colon carcinoma cells.
  • To determine if reduced RII expression is due to transcriptional repression or decreased mRNA stability.

Main Methods:

  • RNase protection assays to analyze RII gene expression and mRNA half-life.
  • Nuclear run-on and RII promoter-reporter (CAT) assays to assess transcriptional levels.
  • Transfection experiments with wild-type and mutant RII constructs.

Main Results:

  • RII gene expression was repressed in RER+ cell lines (HCT116, RKO).
  • Transcriptional levels of RII were not reduced, but mRNA half-lives were significantly decreased in RER+ cells.
  • Mutated RII mRNA exhibited shorter half-lives compared to wild-type RII mRNA.

Conclusions:

  • Reduced RII mRNA levels in RER+ colon carcinoma cells are primarily due to decreased mRNA stability.
  • A frameshift mutation causing a premature stop codon in the RII mRNA transcript is responsible for the reduced mRNA stability and expression.
  • These findings elucidate a mechanism for TGF-beta resistance in colon cancer.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...